Full Breakdown
Investigation into Salmonella Outbreak Linked to Rosabella Moringa Powder
2/18/2026, 7:54:53 AM
Overview of the Outbreak
Public health officials are currently investigating a Salmonella outbreak associated with Rosabella-brand moringa powder. The U.S. Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), and state public health agencies are examining drug-resistant Salmonella infections that may be linked to specific lots of this product. As of now, seven illnesses have been reported across seven states, with three cases resulting in hospitalization.
Affected States and Product Recall
The states affected by the outbreak include Arizona, Florida, Iowa, Illinois, Indiana, Tennessee, and Washington. Ambrosia Brands, the distributor of Rosabella moringa powder, has voluntarily recalled certain lots of the product. The recalled capsules are packaged in a 60-count white bottle with a green lid and label. They were sold through various platforms, including Rosabella's website, TikTok shop, eBay, and Shein. The FDA has specified that the recalled lots all start with SKU number 1356 and end with a -1 or -2 after the lot code, with expiration dates ranging from March 2027 to November 2027.
Health Risks and Consumer Advisory
Health officials are advising consumers to refrain from consuming the affected Rosabella moringa powder capsules. They recommend disposing of the product and thoroughly washing any surfaces that may have come into contact with it. Symptoms of Salmonella infection can include high fever, dehydration, diarrhea, and vomiting, particularly in individuals with compromised immune systems, who are at greater risk for severe illness.
Background on Moringa Powder
Moringa powder is derived from the leaves and pods of the moringa tree, which is native to warm regions worldwide. It is often marketed for its nutritional benefits and is used in beverages aimed at treating various health conditions, including ulcers and hypertension. However, the Cleveland Clinic has noted that many health claims associated with moringa lack substantial scientific evidence, indicating a need for more rigorous research to validate these assertions.
Official Statements & Responses
The CDC and FDA have emphasized the seriousness of the outbreak, urging consumers to take immediate action regarding the recalled product. They continue to monitor the situation and investigate the source of the contamination.
Criticism & Opposition
Some health experts have raised concerns about the marketing of moringa products, suggesting that the claims made by supplement manufacturers often lack adequate scientific backing. This skepticism highlights the need for regulatory scrutiny in the dietary supplement industry to ensure consumer safety.
What's Next
As the investigation unfolds, health officials will continue to track the outbreak and provide updates on any further developments or additional recalls. Consumers are encouraged to stay informed through official health channels regarding the safety of dietary supplements.
